NINLARO 2.3mg capsules TAKEDA ORIGINAL MEDICINE
Chemical substance: ixazomib
ATC code: L01XX50 • Antineoplastic and immunomodulating agents | Other antineoplastic agents
Active substance
Results for the substance ixazomib
3 results
About this active substance
Ixazomib is a medication used to treat multiple myeloma in adult patients who have received at least one prior therapy. It is a proteasome inhibitor that interferes with cellular processes essential for cancer cell survival, leading to their death.
The medication is taken orally, usually once a week, in combination with other drugs, as directed by a doctor.
Side effects may include nausea, vomiting, diarrhea, fatigue, or decreased blood cell counts. In rare cases, severe adverse effects such as peripheral neuropathy or liver failure may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
The medication is taken orally, usually once a week, in combination with other drugs, as directed by a doctor.
Side effects may include nausea, vomiting, diarrhea, fatigue, or decreased blood cell counts. In rare cases, severe adverse effects such as peripheral neuropathy or liver failure may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
-
-
NINLARO 3mg capsules TAKEDA ORIGINAL MEDICINE
Chemical substance: ixazomib
ATC code: L01XX50 • Antineoplastic and immunomodulating agents | Other antineoplastic agents
-
NINLARO 4mg capsules TAKEDA ORIGINAL MEDICINE
Chemical substance: ixazomib
ATC code: L01XX50 • Antineoplastic and immunomodulating agents | Other antineoplastic agents